EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrode Droplet Microarray (eDMA): An Impedance Platform for Label‐Free Parallel Monitoring of Cellular Drug Response in Nanoliter Droplets

Meijun Zhou, Joaquin E Urrutia Gomez iD, Nikolaj K Mandsberg iD, Sida Liu, Sabine Schmidt, Matthias Meier, Pavel A Levkin, Heinz-Georg Jahnke, Anna Popova iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Meijun Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological and Chemical Systems - Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology, Kaiserstrasse 12, 76131, K…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Dielectric Spectroscopy, Toxicity Tests, Microarray Analysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Carlsberg Foundation, Federal Ministry for Economics Affairs and Climate Action of Germany (BMWK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Label‐free real‐time monitoring of cellular behavior using impedance spectroscopy is important for drug development and toxicological assessments. Parallelization and miniaturization of such experiments are essential for increasing throughput and enabling experiments with low abundant stem or primary cells. Traditional methods are not miniaturized and require large volumes of reagents and number of cells, limiting their suitability for cost effective high‐throughput screening of cells of limited availability. Here, the fabrication, optimization, and application of a bioelectrical signaling monitoring system – electrode droplet microarray (eDMA) are demonstrated. The eDMA platform is based on preparation of a hydrophilic‐superhydrophobic patterns covering an array of individually addressable microelectrodes, which confines cells to individual microelectrodes, allowing for parallel, real‐time, and label‐free detection of cellular responses to drug treatments in nanoliter droplets. The real‐time monitoring of cytotoxic effect of an anticancer drug is demonstrated over 48 h with real‐time calculation of the half‐inhibitory concentration (IC50) values through impedance spectroscopy. This demonstrates eDMA's ability to dynamically assess responses to various drugs in parallel at any given time point, which is crucial for functional personalized oncology. Specifically, the platform can be employed for monitoring anticancer drug toxicity using limited patient samples, where the miniaturization provided by eDMA is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDielectric SpectroscopyToxicity TestsMicroarray AnalysisMicroelectrodesElectric ImpedanceHydrophobic and Hydrophilic InteractionsDrug Screening Assays, AntitumorDrug Evaluation, PreclinicalHumansCell Line, Tumor

Stichwörter der Autor:innen

drug screeningelectrode droplet microarrayimpedancelabel‐free

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Institute of Biological and Chemical Systems - Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology, Kaiserstrasse 12, 76131, Karlsruhe, Germany.
  • Karlsruhe Institute of Technology (KIT), Institute of Automation and Applied Informatics (IAI) Eggenstein-Leopoldshafen, 76344, Karlsruhe, Germany.
  • Centre for Biotechnology and Biomedicine, Biochemical Cell Technology, Leipzig University, Deutscher Platz 5, D-04103, Leipzig, Germany.
  • Institute of Organic Chemistry, Karlsruhe Institute of Technology, Kaiserstrasse 12, 76131, Karlsruhe, Germany.

ORCID-Profile: Joaquin E Urrutia Gomez, Nikolaj K Mandsberg, Anna Popova

Förderung

  • Deutsche Forschungsgemeinschaft
  • Carlsberg Foundation
  • Federal Ministry for Economics Affairs and Climate Action of Germany (BMWK)
  • Carlsbergfondet

Zitieren

APA

Zhou, M., Urrutia Gomez, J. E., Mandsberg, N. K., Liu, S., Schmidt, S., Meier, M., Levkin, P. A., Jahnke, H. G., & Popova, A. (2025). Electrode Droplet Microarray (eDMA): An Impedance Platform for Label‐Free Parallel Monitoring of Cellular Drug Response in Nanoliter Droplets. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402046

Vancouver

Zhou M, Urrutia Gomez JE, Mandsberg NK, Liu S, Schmidt S, Meier M, et al. Electrode Droplet Microarray (eDMA): An Impedance Platform for Label‐Free Parallel Monitoring of Cellular Drug Response in Nanoliter Droplets. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402046

BibTeX
@article{Zhou2025,
  author = {Zhou, Meijun and Urrutia Gomez, Joaquin E and Mandsberg, Nikolaj K and Liu, Sida and Schmidt, Sabine and Meier, Matthias and Levkin, Pavel A and Jahnke, Heinz-Georg and Popova, Anna},
  title = {Electrode Droplet Microarray (eDMA): An Impedance Platform for Label‐Free Parallel Monitoring of Cellular Drug Response in Nanoliter Droplets},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402046}
}
Kostenlos starten →